State Street Corp Idera Pharmaceuticals, Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $8.64 $0 - $948,188	-109,744 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.01 - $1.58 $90,227 - $141,147	89,334 Added 437.7%	109,744 $132,000
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $2,460 - $11,960	2,000 Added 10.86%	20,410 $27,000
Q3 2020 Nov 10, 2020	SELL	$1.71 - $2.68 $8,211 - $12,869	-4,802 Reduced 20.69%	18,410 $39,000
Q1 2020 May 11, 2020	BUY	$1.06 - $2.15 $24,604 - $49,905	23,212 New	23,212 $31,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.